ReviewFrontiers in oncology2024
KRAS G12C inhibitor combination therapies: current evidence and challenge.
Hirotaka Miyashita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled itcites it
ReviewFrontiers in oncology2024
Hirotaka Miyashita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.